You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 49 No. 2, February 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Locus Coeruleus Involvement in Huntington's Disease

Richard M. Zweig, MD; C. A. Ross, MD, PhD; J. C. Hedreen, MD; C. Peyser, MD; Joseph E. Cardillo, PhD; S. E. Folstein, MD; D. L. Price, MD

Arch Neurol. 1992;49(2):152-156.


Abstract

• Numbers and areas of neuronal profiles from sections of brain stem at specific anatomic levels of the locus coeruleus and the dorsal raphe nucleus were measured in 33 patients with Huntington's disease and in 23 age-matched control subjects. Results from the Huntington's disease cases were correlated with severity of neostriatal atrophy and with systematically collected quantitative clinical data. Among the patients with Huntington's disease, lower locus coeruleus neuronal counts, reduced neuronal areas, and reduced locus coeruleus length (distance between rostral and caudal levels) were associated with features of advanced disease, including severity of neostriatal atrophy, severity of dementia, duration of illness, and severity of motor impairment and activities of daily living impairment. By contrast, there was no evidence of neuronal pathology within the dorsal raphe nucleus in Huntington's disease. Pathologic changes in the locus coeruleus may relate to some of the clinical manifestations of Huntington's disease.



Author Affiliations

From the Department of Internal Medicine, Neurology Division (Dr Zweig) and Research Office (Dr Cardillo), Veterans Affairs Medical Center, and the University of Nevada School of Medicine, Reno; and the Departments of Psychiatry (Drs Ross, Peyser, and Folstein), Neuroscience (Drs Ross and Price), Pathology (Drs Hedreen and Price), Medicine and Pediatrics (Dr Folstein), and Neurology (Dr Price), The Johns Hopkins University School of Medicine, Baltimore, Md.


Footnotes

Accepted for publication August 29, 1991.

Reprint requests to the Veterans Affairs Medical Center, 1000 Locust St, Reno, NV 89520 (Dr Zweig).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Restoration of Norepinephrine-Modulated Contextual Memory in a Mouse Model of Down Syndrome
Salehi et al.
Sci Transl Med 2009;1:7ra17-7ra17.
ABSTRACT | FULL TEXT  

Rapid Eye Movement Sleep Disturbances in Huntington Disease
Arnulf et al.
Arch Neurol 2008;65:482-488.
ABSTRACT | FULL TEXT  

Crucial role of TrkB ligands in the survival and phenotypic differentiation of developing locus coeruleus noradrenergic neurons
Holm et al.
Development 2003;130:3535-3545.
ABSTRACT | FULL TEXT  

The distribution of structural neuropathology in pre-clinical Huntington's disease
Thieben et al.
Brain 2002;125:1815-1828.
ABSTRACT | FULL TEXT  

Topical Review: Basal Ganglia: Functional Anatomy and Physiology. Part 2
Afifi
J Child Neurol 1994;9:352-361.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.